Skip to main content
. 2013 Jun 18;8(6):e66885. doi: 10.1371/journal.pone.0066885

Figure 6. Reversion of MSO effects by GLN.

Figure 6

MSO (10 µg and 20 µg) was injected into the ipsilateral DG on the third day following the first stage 3 seizure. GLN (1.5 µg) was given 20 min after MSO treatment and was re-administered once daily for next 2 consecutive days. (A) behavioral stage progression of kindled seizures, (B) AD duration. Data are shown as mean ± SEM. *** P<0.001 compared with the control group.